Topical Formulations of Liposomal Local Anesthetics

PHASE1CompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

September 30, 2006

Primary Completion Date

December 31, 2006

Study Completion Date

April 30, 2007

Conditions
Administration, Topical DrugAdministration, TopicalAnesthetic Drugs
Interventions
DRUG

Ropivacaine

100 mg of the following formulations: Liposome-encapsulated 1 and 2% ropivacaine gel, liposome placebo gel and 2.5% lidocaine and 2.5% prilocaine cream were applied once during 5 minutes.

DRUG

Ropivacaine

100 mg of the following formulations: Liposome-encapsulated 1 and 2% ropivacaine gel, liposome placebo gel and 20% benzocaine gel were applied once during 30 minutes.

Trial Locations (1)

13414903

Piracicaba Dental School, Piracicaba

All Listed Sponsors
collaborator

Fundação de Amparo à Pesquisa do Estado de São Paulo

OTHER_GOV

lead

University of Campinas, Brazil

OTHER

NCT01054547 - Topical Formulations of Liposomal Local Anesthetics | Biotech Hunter | Biotech Hunter